Background/Objectives: Although total body skin examination (TBSE) is the primary screening mechanism for melanoma, there is no consensus on which anatomic sites a screening TBSE should include. We sought to establish which anatomic sites are examined during routine (>90%) TBSEs of patients at high risk for skin cancer.
Survey Administration
The study was approved by the Memorial Sloan Ketter- 
Statistical Analysis
Descriptive and relative frequencies along with cross-classifications were used to describe the survey responses. To reduce the potential for type 1 errors based on multiple comparisons, we used the Bonferroni correction and divided the study α-level by the number of comparisons made α/20 ~= 0.002. Proportions were considered statistically different at an α-level of <0.002.
Introduction
Skin cancer is the most common human malignancy, with more than 5 million cases diagnosed in the United States annually [1] . The visible nature of cutaneous malignancies presents a theoretical opportunity for secondary prevention of disease not possible for many other malignancies. Studies have shown that receiving a screening total body skin examination (TBSE) independently increases the likelihood of identifying melanoma and reduces the incidence of thick melanomas. Furthermore, detection of early melanoma results in more treatable disease and better prognosis, with 5-year survival of thin melanoma nearing 99% [2, 3] . However, skin cancer screening, even in the highest risk populations, is controversial, as no prospective randomized controlled trial has been conducted that shows demonstrable mortality benefit. The rationale for our study was therefore to begin to better understand baseline TBSE practices, by first studying the practices of dermatologist skin cancer specialists. The primary objective of our study was to identify which anatomic sites are routinely examined during TBSEs (>90% of the time) in patients at high risk for skin cancer. The secondary objective was to identify the rationale for not examining particular anatomic sites. We hypothesized that obscure anatomic sites are likely infrequently examined during TBSEs even amongst dermatologist skin cancer specialists.
Methods

Participants
The contact information for 173 international dermatologists deemed skin cancer specialists was compiled from (1) board members and executive board members of the Inter- Table 2 presents the frequency by which survey respondents reported routinely examining each anatomic site.
Greater than 75% of participants reported routinely examining the following areas during TBSEs: scalp, ears, face and neck, trunk, breasts, inframammary areas, axillae, extremities, palms and soles, finger and toenails, interdigital spaces, and buttocks. The scalp was reported to be routinely examined by 84% of participants (n = 63). Of those who do not examine the scalp, the primary reason cited was low prevalence of malignancy. The ocular conjunctiva and oral mucosa were routinely examined by fewer than half of participants (n = 35; 46.7%). The main reasons for not examining these sites included the expectation that other specialists examine these areas and low prevalence of malignancy, which is depicted in graphical form in Figure 1 .
The perianal region (n = 26; 34.7%), labia majora (n = 21; 28%), and labia minora (n = 8; n = 10.7%) were infrequently examined. Survey respondents reported routinely screening the scrotum (n = 38; 50.7%) and penis (n = 39; 52%) more often than the female genitalia. The vagina was examined participants (n = 47; 62.7%) had >40% of their clinic devoted to the care of high-risk skin cancer patients.
A majority of survey respondents reported always using dermoscopy for TBSEs (n = 64; 85.3%). Three respondents reported never using dermoscopy for TBSEs. While 20 participants (26.7%) reported using total body photography for comparison during TBSEs in >40% of their high-risk patients, 60 (80%) reported that their examination rooms were equipped with monitors for viewing baseline photos and/or digital dermoscopy. Nearly all participants (n = 69; 92%) stated their examination rooms were equipped with good overhead lighting, while a minority reported their examination rooms were equipped with stirrups, vaginal specula, and hair dryers for the inspection of scalp lesions (n = 16, 21.3%; n = 5, 6.7%; n = 1, 1.3%, respectively).
In preparation for the TBSE, the majority of dermatologists surveyed (n = 44; 58.7%) stated patents are always told to remove all their clothing, including undergarments, and the majority of high-risk patients comply >60% of the time (n = 51; 68%). Within the medical community there is growing recognition of the harms posed by broad-stroked, intuition-based cancer screening where there has been no demonstrable effect on mortality [6] . For melanoma, there is no doubt that finding early-stage localized thin disease reduces mortality [7] . The 5-year melanoma-specific survival for mucosal melanoma is in staunch contrast to that of cutaneous melanoma, 61%
vs 91%, respectively. This raises the inevitable question of whether increased screening of such neglected sites would improve prognosis by identifying early-stage disease. However, before recommending nuanced screening for specific target populations, such as for acral lentiginous melanoma least frequently (n = 2; 2.7%). The primary reason cited for not examining the male/female genitalia included patient discomfort (n = 27/59; 45.7%), with a similar number of participants citing that other specialists examine this area (n = 24/59; 40.7%) and a few also citing low prevalence of malignancy (n = 8/59; 13.6%).
Discussion
To our knowledge, our study is the first to delve deeply into the practices of dermatologists when performing TBSEs, including the content, technique, and rationale. In reviewing the literature pertaining to screening TBSEs, only a few studies explicitly state in their methodology which anatomic sites were screened during TBSEs, and when detailed, anatomic sites examined were not standardized among different studies [3] [4] [5] . Our international survey study showed that both in the United States and abroad, the majority of dermatologists To account for multiple comparisons, a P value of <0.002 was considered significantly different. *Statistically significant result.
melanoma (including the nasal cavity, accessory sinuses, oral cavity, anorectal area, genital tract) was approximately 2 per 1 million [12] . This low incidence is disproportionate when compared to our tendency to over-biopsy; as one study found, more than 1,000 benign nevi were biopsied between 2009 and 2013 in order to detect 1 melanoma in patients under 19 years of age [13] . The low incidence of melanoma in these sites, when contextualized with both the expected morbidity from increased screening and with the already high biopsy rate, raises important questions regarding surveillance recommendations.
In addition to citing low prevalence of malignancy as rationale for not examining oral mucosa, ocular mucosa, and genitalia, many dermatologists in our study also reported that they avoided examination of the genitalia because of patient discomfort. Perceived patient discomfort with examination of sensitive areas may be exacerbated when the gender of the physician differs from that of the patient as studies have corroborated for pelvic examinations, colonoscopies, and even most recently for TBSEs that female patients have a preference toward female physicians [14] [15] [16] . Significantly, studies have shown that patients who were educated on the importance of TBSEs were found to have decreased discomfort when receiving a genital examination [17] .
Perhaps a more effective method for surveillance of such anatomic sites lies in empowering patients to be vigilant in their own skin self-examination. In one study of patients with in dark-skinned populations, or in this case for increased screening of neglected anatomic sites, we caution readers to consider the potential harms of increased surveillance [8, 9] .
To date there is no evidence that surveillance of obscure anatomic sites would result in decreased mortality from melanoma. Mucosal melanoma, as compared to cutaneous melanoma, has a unique mutation signature, distinct pathogenesis, and may be an independently more aggressive disease process. Furthermore, increased surveillance would likely result in an increased number of surgical procedures and increased morbidity. When considering the atypical clinical, dermoscopic, and histopathological spectrum surrounding "nevi of special sites," the expected morbidity and rate of excess surgical intervention would be exacerbated in the genital and perianal sites in specific [10] . As such, clinicians examining these areas must be aware of the degree of clinical atypia present in even benign melanosis [11] . With sensitive anatomic sites, we could expect both functional and cosmetic impairment from repetitive intervention. Such interventions are equally fraught with patient anxiety.
It is equally our burden to weigh the surmounting health care costs associated with increased procedures against the exceedingly low incidence of melanoma in the anatomic sites that our study suggests are infrequently being examined, even in patients at the highest risk for skin cancer. In 2010, statistics from the Surveillance, Epidemiology, End
Results Program database showed the incidence for mucosal 
Conclusions
Our study sheds insight into the screening habits of skin cancer specialists when performing routine TBSEs on patients at high risk for skin cancer. Overall, we found that the genitalia, perianal regions, ocular conjunctiva, and oral mucosa are not routinely examined with the rationale that these anatomic sites are associated with a low prevalence of malignancy and that other experts examine these sites. Further studies that investigate the morbidity, cost-effectiveness, patient preference, and potential mortality benefit of examining particular anatomic sites will help to establish what a routine TBSE should include.
genital melanoma, more than 65% of patients had a 6-month delay before consulting a medical professional, citing embar- [19] . Should these sites be deemed important for surveillance, it is equally important to bridge the gap with other specialties, as well as to educate patients to seek outside examination, to ensure adequate and complete screening.
Our preliminary survey study is notably limited by a small sample of dermatologists who dedicate a portion of their care
to high-risk skin cancer screening and is not a random sample of the dermatology community at large. These findings may in fact be accentuated in a general dermatology clinic. We recognize that with a response rate of 77 (44.5%), our findings are exposed to nonresponse bias, meaning that nonrespondents could be categorically less or more likely to examine obscure sites. Furthermore, given the nature of a retrospective survey study, our results could be exposed to potential response bias.
To this point, however, one would assume that in a survey study, providers would be more likely to overestimate, rather than underestimate, the frequency by which they routinely examine obscure areas in their practice. In the future, it may be helpful to retest a subgroup of respondents to gauge reproducibility of findings.
Our study attempts to reflect the anatomic sites routinely inspected by dermatologists specializing in skin cancer and evaluating patients at increased risk. It highlights the ambiguities that exist regarding what sites should be examined during a routine surveillance examination, and also the variation in how different practitioners conduct TBSEs, and what equipment they have available to aid their examination. We hope our findings stimulate further investigation on which anatomic sites should be routinely evaluated to best reduce melanoma mortality while minimizing morbidity from unnecessary procedures.
